- Home
- NBIX vs DPZ Comparison
NBIX vs DPZ Comparison
Compare NBIX & DPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- DPZ
- Stock Information
- Founded
- NBIX 1992
- DPZ 1960
- Country
- NBIX United States
- DPZ United States
- Employees
- NBIX N/A
- DPZ N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- DPZ Food Distributors
- Sector
- NBIX Health Care
- DPZ Consumer Discretionary
- Exchange
- NBIX Nasdaq
- DPZ Nasdaq
- Market Cap
- NBIX 14.4B
- DPZ 13.9B
- IPO Year
- NBIX 1996
- DPZ 2004
- Fundamental
- Price
- NBIX $138.96
- DPZ $403.47
- Analyst Decision
- NBIX Strong Buy
- DPZ Buy
- Analyst Count
- NBIX 18
- DPZ 22
- Target Price
- NBIX $172.33
- DPZ $487.64
- AVG Volume (30 Days)
- NBIX 1.2M
- DPZ 541.5K
- Earning Date
- NBIX 10-28-2025
- DPZ 10-14-2025
- Dividend Yield
- NBIX N/A
- DPZ 1.73%
- EPS Growth
- NBIX 12.44
- DPZ 5.20
- EPS
- NBIX 4.19
- DPZ 17.13
- Revenue
- NBIX $2,682,700,000.00
- DPZ $4,848,168,000.00
- Revenue This Year
- NBIX $23.68
- DPZ $5.71
- Revenue Next Year
- NBIX $18.02
- DPZ $6.43
- P/E Ratio
- NBIX $33.07
- DPZ $23.55
- Revenue Growth
- NBIX 19.61
- DPZ 3.92
- 52 Week Low
- NBIX $84.23
- DPZ $392.89
- 52 Week High
- NBIX $157.67
- DPZ $500.55
- Technical
- Relative Strength Index (RSI)
- NBIX 41.83
- DPZ 42.83
- Support Level
- NBIX $145.00
- DPZ $402.20
- Resistance Level
- NBIX $148.84
- DPZ $412.77
- Average True Range (ATR)
- NBIX 5.03
- DPZ 8.49
- MACD
- NBIX -0.99
- DPZ 0.89
- Stochastic Oscillator
- NBIX 10.68
- DPZ 55.58
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About DPZ Domino's Pizza Inc
Domino's is a restaurant operator and franchiser with over 21,500 global stores across more than 90 international markets at the end of the second quarter of 2025. The firm generates revenue through the sales of pizza, wings, salads, sandwiches, and desserts at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's US and Canadian restaurants. With roughly $19.2 billion in 2024 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Little Caesars, and Papa John's.